Bulletin
Investor Alert

New York Markets Open in:

Intellia Therapeutics Inc.

NAS: NTLA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 23, 2022, 7:58 p.m.

/zigman2/quotes/207821052/composite

$

44.96

Change

-2.36 -4.99%

Volume

Volume 14,629

Quotes are delayed by 20 min

/zigman2/quotes/207821052/composite

Previous close

$ 47.74

$ 47.32

Change

-0.42 -0.88%

Day low

Day high

$46.48

$49.84

Open

52 week low

52 week high

$38.85

$202.73

Open

John M. Leonard

Dr. John M. Leonard, MD, is an Independent Director at IFM Therapeutics LLC, a Lead Independent Director at IQVIA Holdings, Inc., a President, Chief Executive Officer & Director at Intellia Therapeutics, Inc. and a SVP-Global Pharmaceutical Research & Development at Abbott Laboratories. He is on the Board of Directors at IFM Therapeutics LLC, IQVIA Holdings, Inc., Intellia Therapeutics, Inc., Biotechnology Innovation Organization, IFM Cinque, Inc., IFM Continua, Inc. and IFM Quattro, Inc. Dr. Leonard was previously employed as an Independent Director by Quintiles Transnational Holdings, Inc., an Independent Director by Chimerix, Inc., a CSO, SVP-Pharmaceutical Research & Development by AbbVie, Inc., a Senior VP-Pharmaceuticals, Research & Development by Abbott Laboratories, and a Senior Director-Clinical Research by G.H. Besselaar Associates. He also served on the board at Vitae Pharmaceuticals inc. He received his undergraduate degree from the University of Wisconsin and a doctorate degree from The Johns Hopkins University School of Medicine.

Transactions

Date Shares Transaction Value
03/01/2022 40,990   Award at $0 per share. 0
01/01/2022 2,493   Disposition at $112.26 per share. 279,865
01/01/2022 7,848   Derivative/Non-derivative trans. at $0 per share. 0
09/01/2021 44,735   Disposition at $170 per share. 7,604,950
09/01/2021 15,985   Derivative/Non-derivative trans. at $18.3 per share. 292,525
09/01/2021 28,750   Derivative/Non-derivative trans. at $23.46 per share. 674,475
08/31/2021 37,833   Disposition at $155 per share. 5,864,115
08/31/2021 37,833   Derivative/Non-derivative trans. at $14.58 per share. 551,605
08/30/2021 2,598   Disposition at $159.18 per share. 413,550
08/30/2021 3,123   Disposition at $157.75 per share. 492,654
08/30/2021 4,758   Disposition at $156.96 per share. 746,816
08/30/2021 15,567   Disposition at $155.7 per share. 2,423,782
08/30/2021 7,428   Disposition at $154.98 per share. 1,151,192
08/30/2021 2,334   Disposition at $153.66 per share. 358,643
08/30/2021 2,055   Disposition at $152.81 per share. 314,025
08/30/2021 27,167   Derivative/Non-derivative trans. at $14.58 per share. 396,094
08/30/2021 216   Disposition at $160.69 per share. 34,710
08/30/2021 725   Disposition at $159.98 per share. 115,986
08/30/2021 11,637   Derivative/Non-derivative trans. at $13.4 per share. 155,935
08/23/2021 100   Disposition at $153.52 per share. 15,352
08/23/2021 8,165   Disposition at $153.08 per share. 1,249,899
08/23/2021 18,874   Disposition at $151.54 per share. 2,860,166
08/23/2021 27,139   Derivative/Non-derivative trans. at $13.4 per share. 363,662
08/19/2021 5,963   Disposition at $152.3 per share. 908,165
08/19/2021 6,993   Disposition at $151.56 per share. 1,059,860
08/19/2021 9,726   Disposition at $150.46 per share. 1,463,374
08/19/2021 22,682   Derivative/Non-derivative trans. at $13.4 per share. 303,938
04/13/2021 15,937   Derivative/Non-derivative trans. at $13.88 per share. 221,205
04/13/2021 10,000   Derivative/Non-derivative trans. at $6.83 per share. 68,300
04/01/2021 13,895   Disposition at $83 per share. 1,153,285
04/01/2021 26,041   Derivative/Non-derivative trans. at $13.4 per share. 348,949
04/01/2021 24,314   Disposition at $84 per share. 2,042,376
04/01/2021 45,000   Derivative/Non-derivative trans. at $14.58 per share. 656,100
02/09/2021 28,043   Disposition at $75 per share. 2,103,225
02/09/2021 56,718   Derivative/Non-derivative trans. at $6.83 per share. 387,383
02/05/2021 881   Disposition at $68.78 per share. 60,596
02/05/2021 14,018   Disposition at $67.86 per share. 951,262
02/05/2021 8,043   Disposition at $67.18 per share. 540,329
02/05/2021 40,000   Derivative/Non-derivative trans. at $13.4 per share. 536,000
02/03/2021 36,858   Disposition at $73 per share. 2,690,634
02/03/2021 67,060   Derivative/Non-derivative trans. at $13.88 per share. 930,792
02/03/2021 30,998   Disposition at $72 per share. 2,231,856
02/03/2021 50,000   Derivative/Non-derivative trans. at $22.78 per share. 1,139,000
02/01/2021 30,000   Derivative/Non-derivative trans. at $18.3 per share. 549,000
02/01/2021 693   Disposition at $65.02 per share. 45,059
02/01/2021 3,497   Disposition at $64.16 per share. 224,368
02/01/2021 1,709   Disposition at $63.24 per share. 108,078
02/01/2021 10,000   Derivative/Non-derivative trans. at $13.88 per share. 138,800
02/01/2021 8,827   Disposition at $65 per share. 573,755
02/01/2021 26,058   Disposition at $64.13 per share. 1,671,100
02/01/2021 16,750   Disposition at $63.32 per share. 1,060,610
02/01/2021 5,475   Disposition at $65.04 per share. 356,094
02/01/2021 16,640   Disposition at $64.1 per share. 1,066,624
02/01/2021 11,100   Disposition at $63.3 per share. 702,630
02/01/2021 60,000   Derivative/Non-derivative trans. at $22.78 per share. 1,366,800
02/01/2021 3,260   Disposition at $65.03 per share. 211,998
02/01/2021 9,432   Disposition at $64.09 per share. 604,497
02/01/2021 6,448   Disposition at $63.29 per share. 408,094
02/01/2021 100,000   Derivative/Non-derivative trans. at $6.83 per share. 683,000
01/05/2021 6,239   Disposition at $55.86 per share. 348,511
12/31/2020 14,375   Derivative/Non-derivative trans. at $0 per share. 0
11/27/2020 20,000   Disposition at $39 per share. 780,000
11/27/2020 20,000   Derivative/Non-derivative trans. at $14.58 per share. 291,600
11/27/2020 15,000   Disposition at $38 per share. 570,000
11/27/2020 15,000   Derivative/Non-derivative trans. at $18.3 per share. 274,500
11/25/2020 50,000   Disposition at $36 per share. 1,800,000
11/25/2020 50,000   Derivative/Non-derivative trans. at $6.83 per share. 341,500
11/16/2020 20,000   Disposition at $34 per share. 680,000
11/16/2020 20,000   Derivative/Non-derivative trans. at $14.58 per share. 291,600
11/04/2020 50,000   Disposition at $26 per share. 1,300,000
11/04/2020 50,000   Derivative/Non-derivative trans. at $6.83 per share. 341,500
10/07/2020 5,000   Disposition at $21.83 per share. 109,150
10/07/2020 5,000   Derivative/Non-derivative trans. at $6.83 per share. 34,150
09/01/2020 5,000   Disposition at $21.83 per share. 109,150
09/01/2020 5,000   Derivative/Non-derivative trans. at $6.83 per share. 34,150
08/06/2020 5,000   Disposition at $21.83 per share. 109,150
08/06/2020 5,000   Derivative/Non-derivative trans. at $6.83 per share. 34,150
07/01/2020 5,000   Disposition at $21.83 per share. 109,150
07/01/2020 5,000   Derivative/Non-derivative trans. at $6.83 per share. 34,150
06/03/2020 5,000   Disposition at $21.83 per share. 109,150
06/03/2020 5,000   Derivative/Non-derivative trans. at $6.83 per share. 34,150
05/14/2018 8,400   Disposition at $24 per share. 201,600
06/01/2017 600   Award at $12.09 per share. 7,254
06/01/2017 7,800   Award at $12.06 per share. 94,068

Officers and Executives

Dr. John M. Leonard
President, Chief Executive Officer & Director
Mr. Glenn Goddard
Treasurer, Chief Financial & Accounting Officer
Dr. Laura Sepp-Lorenzino
Chief Scientific Officer & Executive VP
Dr. Eliana Clark
Chief Technology Officer & Executive VP
Dr. David Lebwohl
Chief Medical Officer & Executive Vice President
Dr. Christine Foster
SVP-Business Development & Alliance Management
Mr. Derek Hicks
Chief Business Officer & Executive Vice President
Mr. Ian Karp
Senior Vice President-Corporate Communications
Ms. Marika St Amand
Chief Human Resources Officer
Mr. James Basta
Secretary, Executive VP & General Counsel
Dr. Frank A. G. M. Verwiel
Chairman
Mr. John Francis Crowley
Independent Director
Dr. Georgia Keresty
Independent Director
Ms. Muna Bhanji
Independent Director
Dr. Jean-Francois B. Formela
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Jesse L. Goodman
Independent Director
Dr. Fred Ehrenkranz Cohen
Independent Director
Link to MarketWatch's Slice.